botensilimab,balstilimab
agenus
read more about our journey to esmo gi, and the impact we hope our botensilimab data has on mss crc research, over at : 
Our goal is to treat cancers with novel combinations using our unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines & adjuvants